1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares, » Read more about: 1 Rare Stock Buffett Is Buying »
Read More
Is Palantir on the Precipice of a Sharp Fall?
Palantir (NYSE:PLTR) has been among the biggest beneficiaries of this year’s AI bull run and the more recent post-election rally. The stock started this year at just $16.58 and has since skyrocketed to over $60 per share.
The last month has been particularly dramatic when PLTR started November a little over $40 before being pushed skyward following election news that was deemed positive and a stellar Q3 earnings report.
» Read more about: Is Palantir on the Precipice of a Sharp Fall? »
Read More
Will Trump’s Energy Secretary Pick Drive Oklo Higher?
Oklo (NYSE: OKLO) shares surged over 18% Monday after President-elect Donald Trump named Liberty Energy CEO Chris Wright as his pick for Energy Secretary.
For Oklo investors, the selection carries special significance – Wright currently serves on Oklo’s board of directors, potentially giving the nuclear innovation company an influential ally in Washington just as it hits its stride with commercial deployments and new acquisitions.
» Read more about: Will Trump’s Energy Secretary Pick Drive Oklo Higher? »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read More
How To Trade When Markets Hit All-time Highs
With the market near all-time highs, buying stocks can look like a worrisome proposition and it’s no surprise that many investors feel more comfortable sitting on the sidelines.
Staying out of the market entirely, though, presents an opportunity cost in the form of lost potential returns. So, just what can investors worried about the market’s performance and potential volatility do to limit their risks while still putting their money to work for them?
» Read more about: How To Trade When Markets Hit All-time Highs »
Read MoreThe Ivy
1 Low-Cost Schwab ETF That Beat The Market
With around $65.7 billion in net assets, Schwab’s US Dividend Equity ETF (SCHD) is one of the most popular funds among investors seeking dividend income from their portfolios.
In the last year, SCHD has even beaten out the S&P 500 by delivering a 27.1% market price return compared to 25.0% from the S&P.
» Read more about: 1 Low-Cost Schwab ETF That Beat The Market »
Read MoreThe Spotlight
1 Defense Contractor Going Global
Lockheed Martin Corporation (NYSE:LMT) is doing very well and making great progress with its 21st Century Security® strategy. The bold plan concentrates on three main initiatives that aim to boost the company’s role in the defense and aerospace industries.
The first initiative focuses on making Lockheed Martin’s production system stronger and able to handle more.
» Read more about: 1 Defense Contractor Going Global »
Read MoreThe Daily
New budget projections show US hitting debt record in 4 years: CBO
<!–>
Reps. Claudia Tenney, R-N.Y., and Lloyd Smucker, R-Pa., discuss efforts to unleash the economy on ‘Kudlow.’
The nonpartisan Congressional Budget Office (CBO) released its latest 10-year budget and economic outlook Friday that showed the federal government is on track to break a debt record set nearly 80 years ago.
» Read more about: New budget projections show US hitting debt record in 4 years: CBO »